Indeed, a review of exome sequencing data (N = 2078 CRCs from cbioportal) showed a high prevalence of JAK1/2 mutations, but not of STAT5, in hypermutated tumours [10, 14] (Additional file 3: Figure S2a). The gene discussed is STAT5B; the disease is neoplasm.